These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. A new way APP mismetabolism can lead to Alzheimer's disease. Hardy J; Guerreiro R EMBO Mol Med; 2011 May; 3(5):247-8. PubMed ID: 21523909 [No Abstract] [Full Text] [Related]
31. A cell biological perspective on Alzheimer's disease. Annaert W; De Strooper B Annu Rev Cell Dev Biol; 2002; 18():25-51. PubMed ID: 12142279 [TBL] [Abstract][Full Text] [Related]
32. Ginsenoside Rg1 attenuates β-amyloid generation via suppressing PPARγ-regulated BACE1 activity in N2a-APP695 cells. Chen LM; Lin ZY; Zhu YG; Lin N; Zhang J; Pan XD; Chen XC Eur J Pharmacol; 2012 Jan; 675(1-3):15-21. PubMed ID: 22166376 [TBL] [Abstract][Full Text] [Related]
33. [Progress in the development of anti-amyloid drugs for treatment of Alzheimer's disease.]. Shitaka Y; Mitani Y; Nagakura A; Miyake A; Matsuoka N Nihon Yakurigaku Zasshi; 2010 Jul; 136(1):15-20. PubMed ID: 20628208 [No Abstract] [Full Text] [Related]
34. Generation of aggregation prone N-terminally truncated amyloid β peptides by meprin β depends on the sequence specificity at the cleavage site. Schönherr C; Bien J; Isbert S; Wichert R; Prox J; Altmeppen H; Kumar S; Walter J; Lichtenthaler SF; Weggen S; Glatzel M; Becker-Pauly C; Pietrzik CU Mol Neurodegener; 2016 Feb; 11():19. PubMed ID: 26895626 [TBL] [Abstract][Full Text] [Related]
35. Effects of altered RTN3 expression on BACE1 activity and Alzheimer's neuritic plaques. Sharoar MG; Yan R Rev Neurosci; 2017 Feb; 28(2):145-154. PubMed ID: 27883331 [TBL] [Abstract][Full Text] [Related]
36. Abnormalities of peptide metabolism in Alzheimer disease. Panchal M; Rholam M; Brakch N Curr Neurovasc Res; 2004 Oct; 1(4):317-23. PubMed ID: 16181081 [TBL] [Abstract][Full Text] [Related]
37. Lipid rafts play an important role in A beta biogenesis by regulating the beta-secretase pathway. Tun H; Marlow L; Pinnix I; Kinsey R; Sambamurti K J Mol Neurosci; 2002; 19(1-2):31-5. PubMed ID: 12212790 [TBL] [Abstract][Full Text] [Related]
38. Potential treatment opportunities for Alzheimer's disease through inhibition of secretases and Abeta immunization. Schenk D; Games D; Seubert P J Mol Neurosci; 2001 Oct; 17(2):259-67. PubMed ID: 11816797 [TBL] [Abstract][Full Text] [Related]
39. Amyloid β Protein Aggravates Neuronal Senescence and Cognitive Deficits in 5XFAD Mouse Model of Alzheimer's Disease. Wei Z; Chen XC; Song Y; Pan XD; Dai XM; Zhang J; Cui XL; Wu XL; Zhu YG Chin Med J (Engl); 2016 Aug; 129(15):1835-44. PubMed ID: 27453234 [TBL] [Abstract][Full Text] [Related]
40. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models. Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]